Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

429 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
MDS-520 A Phase I/II Study of Venetoclax in Combination With ASTX727 (Decitabine/Cedazuridine) in Treatment-Naïve High-Risk Myelodysplastic Syndrome (MDS) or Chronic Myelomonocytic Leukemia (CMML).
Venugopal S, Kantarjian H, Maiti A, Short NJ, Montalban-Bravo G, Alvarado Y, Chien K, Kanagal-Shamanna R, Pemmaraju N, Daver N, Kadia T, Borthakur G, Jabbour E, Garcia-Manero G. Venugopal S, et al. Among authors: maiti a. Clin Lymphoma Myeloma Leuk. 2022 Oct;22 Suppl 2:S321. doi: 10.1016/S2152-2650(22)01427-6. Clin Lymphoma Myeloma Leuk. 2022. PMID: 36163977 Clinical Trial.
AML-147 C-MYC Targeting by Degradation: Novel Dual c-Myc/GSPT1 Degrader GT19715 Exerts Profound Cell Kill In Vitro and In Vivo in Acute Myeloid Leukemia and Lymphomas.
Nishida Y, Scruggs DA, Ayoub E, Patsilevas T, Ruvolo VR, Mak PY, Carter BZ, Boettcher S, Maiti A, Zhou Q, Yang Z, Yan H, Ma L, Andreeff M. Nishida Y, et al. Among authors: maiti a. Clin Lymphoma Myeloma Leuk. 2022 Oct;22 Suppl 2:S218. doi: 10.1016/S2152-2650(22)01230-7. Clin Lymphoma Myeloma Leuk. 2022. PMID: 36163775
Carbodicarbenes and Striking Redox Transitions of their Conjugate Acids: Influence of NHC vs. CAAC as Donor Substituents.
Dolai R, Kumar R, Elvers BJ, Pal PK, Joseph B, Sikari R, Nayak MK, Maiti A, Singh T, Chrysochos N, Jayaraman A, Krummenacher I, Mondal J, Priyakumar UD, Braunschweig H, Yildiz CB, Schulzke C, Jana A. Dolai R, et al. Among authors: maiti a. Chemistry. 2022 Sep 21. doi: 10.1002/chem.202202888. Online ahead of print. Chemistry. 2022. PMID: 36129127
429 results